-
1
-
-
0028004183
-
Models of the diffusional spread of nitric oxide: Implications for neural nitric oxide signalling and its pharmacological properties
-
Wood J, Garthwaite J. Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties. Neuropharmacology 1994; 33: 1235-44.
-
(1994)
Neuropharmacology
, vol.33
, pp. 1235-1244
-
-
Wood, J.1
Garthwaite, J.2
-
2
-
-
0031425115
-
A tutorial on the diffusibility and reactivity of free nitric oxide
-
Lancaster JR, Jr. A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1997; 1: 18-30.
-
(1997)
Nitric Oxide
, vol.1
, pp. 18-30
-
-
Lancaster Jr., J.R.1
-
3
-
-
33750689471
-
Shattuck lecture. Nitric oxide and cyclic GMP in cell signaling and drug development
-
Murad F. Shattuck lecture. Nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med 2006; 355: 2003-11.
-
(2006)
N Engl J Med
, vol.355
, pp. 2003-2011
-
-
Murad, F.1
-
4
-
-
0031623305
-
Nitric oxide signaling: Would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone?
-
Murad F. Nitric oxide signaling: would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone? Recent Prog Horm Res 1998; 53: 43-59.
-
(1998)
Recent Prog Horm Res
, vol.53
, pp. 43-59
-
-
Murad, F.1
-
5
-
-
0032575530
-
Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: A potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity
-
Zhang Z, Naughton D, Winyard PG, Benjamin N, Blake DR, Symons MC. Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity. Biochem Biophys Res Commun 1998; 249: 767-72.
-
(1998)
Biochem Biophys Res Commun
, vol.249
, pp. 767-772
-
-
Zhang, Z.1
Naughton, D.2
Winyard, P.G.3
Benjamin, N.4
Blake, D.R.5
Symons, M.C.6
-
6
-
-
31744451494
-
Endothelial nitric oxide synthase reduces nitrite anions to NO under anoxia
-
Gautier C, van Faassen E, Mikula I, Martasek P, Slama-Schwok A. Endothelial nitric oxide synthase reduces nitrite anions to NO under anoxia. Biochem Biophys Res Commun 2006; 341: 816-21.
-
(2006)
Biochem Biophys Res Commun
, vol.341
, pp. 816-821
-
-
Gautier, C.1
van Faassen, E.2
Mikula, I.3
Martasek, P.4
Slama-Schwok, A.5
-
8
-
-
0033074477
-
Inducible nitric oxide synthase with transitional cell carcinoma of the bladder
-
Swana HS, Smith SD, Perrotta PL, Saito N, Wheeler MA, Weiss RM. Inducible nitric oxide synthase with transitional cell carcinoma of the bladder. J Urol 1999; 161: 630-4.
-
(1999)
J Urol
, vol.161
, pp. 630-634
-
-
Swana, H.S.1
Smith, S.D.2
Perrotta, P.L.3
Saito, N.4
Wheeler, M.A.5
Weiss, R.M.6
-
9
-
-
22844435313
-
Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in association with neovascularization in human primary astrocytoma
-
Pan JW, Zhan RY, Tong Y, Zhou YQ, Zhang M. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in association with neovascularization in human primary astrocytoma. J Zhejiang Univ Sci B 2005; 6: 693-8.
-
(2005)
J Zhejiang Univ Sci B
, vol.6
, pp. 693-698
-
-
Pan, J.W.1
Zhan, R.Y.2
Tong, Y.3
Zhou, Y.Q.4
Zhang, M.5
-
10
-
-
3242674366
-
Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: Correlation with angiogenesis and prognostic significance
-
Hara A, Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol 2004; 108: 43-8.
-
(2004)
Acta Neuropathol
, vol.108
, pp. 43-48
-
-
Hara, A.1
Okayasu, I.2
-
11
-
-
0034083406
-
Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas
-
Vakkala M, Kahlos K, Lakari E, Paakko P, Kinnula V, Soini Y. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. Clin Cancer Res 2000; 6: 2408-16.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 2408-2416
-
-
Vakkala, M.1
Kahlos, K.2
Lakari, E.3
Paakko, P.4
Kinnula, V.5
Soini, Y.6
-
12
-
-
23744465234
-
Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: An immunohistochemical study of 151 cases
-
Bulut AS, Erden E, Sak SD, Doruk H, Kursun N, Dincol D. Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases. Virchows Arch 2005; 447: 24-30.
-
(2005)
Virchows Arch
, vol.447
, pp. 24-30
-
-
Bulut, A.S.1
Erden, E.2
Sak, S.D.3
Doruk, H.4
Kursun, N.5
Dincol, D.6
-
13
-
-
19944434036
-
The role of early expression of inducible nitric oxide synthase in human breast cancer
-
Loibl S, Buck A, Strank C, von Minckwitz G, Roller M, Sinn HP, et al. The role of early expression of inducible nitric oxide synthase in human breast cancer. Eur J Cancer 2005; 41: 265-71.
-
(2005)
Eur J Cancer
, vol.41
, pp. 265-271
-
-
Loibl, S.1
Buck, A.2
Strank, C.3
von Minckwitz, G.4
Roller, M.5
Sinn, H.P.6
-
14
-
-
27144471684
-
Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy
-
Chen HH, Su WC, Chou CY, Guo HR, Ho SY, Que J, et al. Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005; 63: 1093-100.
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.63
, pp. 1093-1100
-
-
Chen, H.H.1
Su, W.C.2
Chou, C.Y.3
Guo, H.R.4
Ho, S.Y.5
Que, J.6
-
15
-
-
0032923041
-
Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue
-
Kojima M, Morisaki T, Tsukahara Y, Uchiyama A, Matsunari Y, Mibu R, et al. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J Surg Oncol 1999; 70: 222-9.
-
(1999)
J Surg Oncol
, vol.70
, pp. 222-229
-
-
Kojima, M.1
Morisaki, T.2
Tsukahara, Y.3
Uchiyama, A.4
Matsunari, Y.5
Mibu, R.6
-
16
-
-
0034660889
-
Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): In vitro antiproliferative effects of a COX-2 inhibitor
-
Marrogi A, Pass HI, Khan M, Metheny-Barlow LJ, Harris CC, Gerwin BI. Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor. Cancer Res 2000; 60: 3696-700.
-
(2000)
Cancer Res
, vol.60
, pp. 3696-3700
-
-
Marrogi, A.1
Pass, H.I.2
Khan, M.3
Metheny-Barlow, L.J.4
Harris, C.C.5
Gerwin, B.I.6
-
17
-
-
16344387665
-
A risk model for non-small cell lung cancer using clinicopathological variables, angiogenesis and oncoprotein expression
-
Rubio L, Vera-Sempere FJ, Lopez-Guerrero JA, Padilla J, Moreno-Baylach MJ. A risk model for non-small cell lung cancer using clinicopathological variables, angiogenesis and oncoprotein expression. Anticancer Res 2005; 25: 497-504.
-
(2005)
Anticancer Res
, vol.25
, pp. 497-504
-
-
Rubio, L.1
Vera-Sempere, F.J.2
Lopez-Guerrero, J.A.3
Padilla, J.4
Moreno-Baylach, M.J.5
-
18
-
-
1342300679
-
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: Correlation with clinical outcome
-
Raspollini MR, Amunni G, Villanucci A, Boddi V, Baroni G, Taddei A, et al. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome. Gynecol Oncol 2004; 92: 806-12.
-
(2004)
Gynecol Oncol
, vol.92
, pp. 806-812
-
-
Raspollini, M.R.1
Amunni, G.2
Villanucci, A.3
Boddi, V.4
Baroni, G.5
Taddei, A.6
-
19
-
-
3543109116
-
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: Correlation with microvessel density
-
Kasper HU, Wolf H, Drebber U, Wolf HK, Kern MA. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density. World J Gastroenterol 2004; 10: 1918-22.
-
(2004)
World J Gastroenterol
, vol.10
, pp. 1918-1922
-
-
Kasper, H.U.1
Wolf, H.2
Drebber, U.3
Wolf, H.K.4
Kern, M.A.5
-
20
-
-
0033862814
-
The prognostic value of inducible nitric oxide synthase in local prostate cancer
-
Aaltomaa SH, Lipponen PK, Viitanen J, Kankkunen JP, Ala-Opas MY, Kosma VM. The prognostic value of inducible nitric oxide synthase in local prostate cancer. BJU Int 2000; 86: 234-9.
-
(2000)
BJU Int
, vol.86
, pp. 234-239
-
-
Aaltomaa, S.H.1
Lipponen, P.K.2
Viitanen, J.3
Kankkunen, J.P.4
Ala-Opas, M.Y.5
Kosma, V.M.6
-
21
-
-
0034992550
-
Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions
-
Massi D, Franchi A, Sardi I, Magnelli L, Paglierani M, Borgognoni L, et al. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions. J Pathol 2001; 194: 194-200.
-
(2001)
J Pathol
, vol.194
, pp. 194-200
-
-
Massi, D.1
Franchi, A.2
Sardi, I.3
Magnelli, L.4
Paglierani, M.5
Borgognoni, L.6
-
22
-
-
33749239628
-
The role of nitric oxide in mediating tumour blood flow
-
Van Buren G, 2nd, Camp ER, Yang AD, Gray MJ, Fan F, Somcio R, et al. The role of nitric oxide in mediating tumour blood flow. Expert Opin TherTargets 2006; 10: 689-701.
-
(2006)
Expert Opin TherTargets
, vol.10
, pp. 689-701
-
-
Van Buren 2nd, G.1
Camp, E.R.2
Yang, A.D.3
Gray, M.J.4
Fan, F.5
Somcio, R.6
-
24
-
-
47049128882
-
Molecular mechanisms for discrete nitric oxide levels in cancer
-
Ridnour LA, Thomas DD, Switzer C, Flores-Santana W, Isenberg JS, Ambs S, et al. Molecular mechanisms for discrete nitric oxide levels in cancer. Nitric Oxide 2008; 19: 73-6.
-
(2008)
Nitric Oxide
, vol.19
, pp. 73-76
-
-
Ridnour, L.A.1
Thomas, D.D.2
Switzer, C.3
Flores-Santana, W.4
Isenberg, J.S.5
Ambs, S.6
-
26
-
-
33847711009
-
An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer
-
Ying L, Hofseth LJ. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res 2007; 67: 1407-10.
-
(2007)
Cancer Res
, vol.67
, pp. 1407-1410
-
-
Ying, L.1
Hofseth, L.J.2
-
27
-
-
0029998870
-
Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth
-
Doi K, Akaike T, Horie H, Noguchi Y, Fujii S, Beppu T, et al. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 1996; 77: 1598-604.
-
(1996)
Cancer
, vol.77
, pp. 1598-1604
-
-
Doi, K.1
Akaike, T.2
Horie, H.3
Noguchi, Y.4
Fujii, S.5
Beppu, T.6
-
28
-
-
0026460303
-
Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature
-
Andrade SP, Hart IR, Piper PJ. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br J Pharmacol 1992; 107: 1092-5.
-
(1992)
Br J Pharmacol
, vol.107
, pp. 1092-1095
-
-
Andrade, S.P.1
Hart, I.R.2
Piper, P.J.3
-
29
-
-
0028219105
-
Upstream modification of vasoconstrictor responses in rat epigastric artery supplying an implanted tumour
-
Kennovin GD, Flitney FW, Hirst DG. "Upstream" modification of vasoconstrictor responses in rat epigastric artery supplying an implanted tumour. Adv Exp Med Biol 1994; 345: 411-6.
-
(1994)
Adv Exp Med Biol
, vol.345
, pp. 411-416
-
-
Kennovin, G.D.1
Flitney, F.W.2
Hirst, D.G.3
-
30
-
-
0001635282
-
Inducible nitric oxide synthase is expressed in tumour-associated vasculature: Inhibition retards tumour growth
-
Moncada S, Feelisch M, Busse R, Higgs EA, Eds, London: Portland Press
-
Kennovin GD, Hirst DG, Stratford MRL, Flitney FW. Inducible nitric oxide synthase is expressed in tumour-associated vasculature: inhibition retards tumour growth. In: Moncada S, Feelisch M, Busse R, Higgs EA, Eds. The biology of nitric oxide. London: Portland Press 1994; pp. 259-63.
-
(1994)
The biology of nitric oxide
, pp. 259-263
-
-
Kennovin, G.D.1
Hirst, D.G.2
Stratford, M.R.L.3
Flitney, F.W.4
-
31
-
-
0029958962
-
Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice
-
Orucevic A, Lala PK. Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice. Cell Immunol 1996; 169: 125-32.
-
(1996)
Cell Immunol
, vol.169
, pp. 125-132
-
-
Orucevic, A.1
Lala, P.K.2
-
32
-
-
0033764533
-
Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions
-
de Wilt JH, Manusama ER, van Etten B, van Tiel ST, Jorna AS, Seynhaeve AL, et al. Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions. Br J Cancer 2000; 83: 1176-82.
-
(2000)
Br J Cancer
, vol.83
, pp. 1176-1182
-
-
de Wilt, J.H.1
Manusama, E.R.2
van Etten, B.3
van Tiel, S.T.4
Jorna, A.S.5
Seynhaeve, A.L.6
-
33
-
-
33646392715
-
Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer
-
Camp ER, Yang A, Liu W, Fan F, Somcio R, Hicklin DJ, et al. Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer. Clin Cancer Res 2006; 12: 2628-33.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 2628-2633
-
-
Camp, E.R.1
Yang, A.2
Liu, W.3
Fan, F.4
Somcio, R.5
Hicklin, D.J.6
-
34
-
-
61849136323
-
Modulators of arginine metabolism support cancer immuno-surveillance
-
Capuano G, Rigamonti N, Grioni M, Freschi M, Bellone M. Modulators of arginine metabolism support cancer immuno-surveillance. BMC Immunol 2009; 10: 1.
-
(2009)
BMC Immunol
, vol.10
, pp. 1
-
-
Capuano, G.1
Rigamonti, N.2
Grioni, M.3
Freschi, M.4
Bellone, M.5
-
35
-
-
0029061096
-
Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma
-
Meyer RE, Shan S, DeAngelo J, Dodge RK, Bonaventura J, Ong ET, et al. Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma. Br J Cancer 1995; 71: 1169-74.
-
(1995)
Br J Cancer
, vol.71
, pp. 1169-1174
-
-
Meyer, R.E.1
Shan, S.2
DeAngelo, J.3
Dodge, R.K.4
Bonaventura, J.5
Ong, E.T.6
-
36
-
-
0031018039
-
Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine
-
Tozer GM, Prise VE, Chaplin DJ. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. Cancer Res 1997; 57: 948-55.
-
(1997)
Cancer Res
, vol.57
, pp. 948-955
-
-
Tozer, G.M.1
Prise, V.E.2
Chaplin, D.J.3
-
37
-
-
0032479884
-
Effects of nitric oxide modulation on tumour blood flow and microvascular permeability in C6 glioma
-
Swaroop GR, Malcolm GP, Kelly PA, Ritchie I, Whittle IR. Effects of nitric oxide modulation on tumour blood flow and microvascular permeability in C6 glioma. Neuroreport 1998; 9: 2577-81.
-
(1998)
Neuroreport
, vol.9
, pp. 2577-2581
-
-
Swaroop, G.R.1
Malcolm, G.P.2
Kelly, P.A.3
Ritchie, I.4
Whittle, I.R.5
-
38
-
-
0034531038
-
The effects of chronic nitric oxide synthase suppression on glioma pathophysiology
-
Swaroop GR, Kelly PA, Bell HS, Shinoda J, Yamaguchi S, Whittle IR. The effects of chronic nitric oxide synthase suppression on glioma pathophysiology. Br J Neurosurg 2000; 14: 543-8.
-
(2000)
Br J Neurosurg
, vol.14
, pp. 543-548
-
-
Swaroop, G.R.1
Kelly, P.A.2
Bell, H.S.3
Shinoda, J.4
Yamaguchi, S.5
Whittle, I.R.6
-
39
-
-
0027321828
-
The central effects of a nitric oxide synthase inhibitor (N omega-nitro-L-arginine) on blood pressure and plasma renin
-
el Karib AO, Sheng J, Betz AL, Malvin RL. The central effects of a nitric oxide synthase inhibitor (N omega-nitro-L-arginine) on blood pressure and plasma renin. Clin Exp Hypertens 1993; 15: 819-32.
-
(1993)
Clin Exp Hypertens
, vol.15
, pp. 819-832
-
-
el Karib, A.O.1
Sheng, J.2
Betz, A.L.3
Malvin, R.L.4
-
40
-
-
0027739308
-
Inhibition of nitric oxide synthesis increases blood pressure in healthy humans
-
Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 1993; 11: 1375-80.
-
(1993)
J Hypertens
, vol.11
, pp. 1375-1380
-
-
Haynes, W.G.1
Noon, J.P.2
Walker, B.R.3
Webb, D.J.4
-
41
-
-
33750700517
-
Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension
-
Kanagy NL. Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension. Am J Physiol 1997; 273: H2756-64.
-
(1997)
Am J Physiol
, vol.273
-
-
Kanagy, N.L.1
-
42
-
-
48749087838
-
Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: Effect of L-arginine and spironolactone
-
Paulis L, Matuskova J, Adamcova M, Pelouch V, Simko J, Krajcirovicova K, et al. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone. Acta Physiol (Oxf) 2008; 194: 45-55.
-
(2008)
Acta Physiol (Oxf)
, vol.194
, pp. 45-55
-
-
Paulis, L.1
Matuskova, J.2
Adamcova, M.3
Pelouch, V.4
Simko, J.5
Krajcirovicova, K.6
-
43
-
-
44649183901
-
Regression of L-NAME-induced hypertension: The role of nitric oxide and endothelium-derived constricting factor
-
Paulis L, Zicha J, Kunes J, Hojna S, Behuliak M, Celec P, et al. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor. Hypertens Res 2008; 31: 793-803.
-
(2008)
Hypertens Res
, vol.31
, pp. 793-803
-
-
Paulis, L.1
Zicha, J.2
Kunes, J.3
Hojna, S.4
Behuliak, M.5
Celec, P.6
-
44
-
-
23744506248
-
L-NAME induces direct arteriolar leukocyte adhesion, which is mainly mediated by angiotensin-II
-
Nabah YN, Mateo T, Cerda-Nicolas M, Alvarez A, Martinez M, Issekutz AC, et al. L-NAME induces direct arteriolar leukocyte adhesion, which is mainly mediated by angiotensin-II. Microcirculation 2005; 12: 443-53.
-
(2005)
Microcirculation
, vol.12
, pp. 443-453
-
-
Nabah, Y.N.1
Mateo, T.2
Cerda-Nicolas, M.3
Alvarez, A.4
Martinez, M.5
Issekutz, A.C.6
-
45
-
-
33846546058
-
Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: A phase I study
-
Ng QS, Goh V, Milner J, Stratford MR, Folkes LK, Tozer GM, et al. Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. Lancet Oncol 2007; 8: 111-8.
-
(2007)
Lancet Oncol
, vol.8
, pp. 111-118
-
-
Ng, Q.S.1
Goh, V.2
Milner, J.3
Stratford, M.R.4
Folkes, L.K.5
Tozer, G.M.6
-
46
-
-
0030877443
-
Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: Studies with 1400W, a novel inhibitor
-
Thomsen LL, Scott JM, Topley P, Knowles RG, Keerie AJ, Frend AJ. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res 1997; 57: 3300-4.
-
(1997)
Cancer Res
, vol.57
, pp. 3300-3304
-
-
Thomsen, L.L.1
Scott, J.M.2
Topley, P.3
Knowles, R.G.4
Keerie, A.J.5
Frend, A.J.6
-
47
-
-
22644432694
-
Anti-cancer effect of iNOS inhibitor and its correlation with angiogenesis in gastric cancer
-
Wang GY, Ji B, Wang X, Gu JH. Anti-cancer effect of iNOS inhibitor and its correlation with angiogenesis in gastric cancer. World J Gastroenterol 2005; 11: 3830-3.
-
(2005)
World J Gastroenterol
, vol.11
, pp. 3830-3833
-
-
Wang, G.Y.1
Ji, B.2
Wang, X.3
Gu, J.H.4
-
48
-
-
65549126881
-
Aminoguanidine impedes human pancreatic tumor growth and metastasis development in nude mice
-
Mohamad NA, Cricco GP, Sambuco LA, Croci M, Medina VA, Gutierrez AS, et al. Aminoguanidine impedes human pancreatic tumor growth and metastasis development in nude mice. World J Gastroenterol 2009; 15: 1065-71.
-
(2009)
World J Gastroenterol
, vol.15
, pp. 1065-1071
-
-
Mohamad, N.A.1
Cricco, G.P.2
Sambuco, L.A.3
Croci, M.4
Medina, V.A.5
Gutierrez, A.S.6
-
49
-
-
0030865655
-
Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells
-
Chin K, Kurashima Y, Ogura T, Tajiri H, Yoshida S, Esumi H. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 1997; 15: 437-42.
-
(1997)
Oncogene
, vol.15
, pp. 437-442
-
-
Chin, K.1
Kurashima, Y.2
Ogura, T.3
Tajiri, H.4
Yoshida, S.5
Esumi, H.6
-
50
-
-
0027220134
-
Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability
-
Wood PJ, Stratford IJ, Adams GE, Szabo C, Thiemermann C, Vane JR. Modification of energy metabolism and radiation response of a murine tumour by changes in nitric oxide availability. Biochem Biophys Res Commun 1993; 192: 505-10.
-
(1993)
Biochem Biophys Res Commun
, vol.192
, pp. 505-510
-
-
Wood, P.J.1
Stratford, I.J.2
Adams, G.E.3
Szabo, C.4
Thiemermann, C.5
Vane, J.R.6
-
51
-
-
0028659788
-
Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine
-
Wood PJ, Sansom JM, Butler SA, Stratford IJ, Cole SM, Szabo C, et al. Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine. Cancer Res 1994; 54: 6458-63.
-
(1994)
Cancer Res
, vol.54
, pp. 6458-6463
-
-
Wood, P.J.1
Sansom, J.M.2
Butler, S.A.3
Stratford, I.J.4
Cole, S.M.5
Szabo, C.6
-
52
-
-
0024584020
-
Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells
-
Stuehr DJ, Nathan CF. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989 1; 169: 1543-55.
-
(1989)
J Exp Med
, vol.1
, Issue.169
, pp. 1543-1555
-
-
Stuehr, D.J.1
Nathan, C.F.2
-
53
-
-
0025860655
-
Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells
-
Li LM, Kilbourn RG, Adams J, Fidler IJ. Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res 1991; 51: 2531-5.
-
(1991)
Cancer Res
, vol.51
, pp. 2531-2535
-
-
Li, L.M.1
Kilbourn, R.G.2
Adams, J.3
Fidler, I.J.4
-
54
-
-
0026069593
-
Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells
-
Li LM, Nicolson GL, Fidler IJ. Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Res 1991; 51: 245-54.
-
(1991)
Cancer Res
, vol.51
, pp. 245-254
-
-
Li, L.M.1
Nicolson, G.L.2
Fidler, I.J.3
-
55
-
-
0025672648
-
Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
-
Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043-47.
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, pp. 10043-10047
-
-
Radomski, M.W.1
Palmer, R.M.2
Moncada, S.3
-
57
-
-
0027408207
-
Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release
-
Maragos CM, Wang JM, Hrabie JA, Oppenheim JJ, Keefer LK. Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release. Cancer Res 1993; 53: 564-8.
-
(1993)
Cancer Res
, vol.53
, pp. 564-568
-
-
Maragos, C.M.1
Wang, J.M.2
Hrabie, J.A.3
Oppenheim, J.J.4
Keefer, L.K.5
-
58
-
-
0029086311
-
Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells
-
Shami PJ, Moore JO, Gockerman JP, Hathorn JW, Misukonis MA, Weinberg JB. Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells. Leuk Res 1995; 19: 527-33.
-
(1995)
Leuk Res
, vol.19
, pp. 527-533
-
-
Shami, P.J.1
Moore, J.O.2
Gockerman, J.P.3
Hathorn, J.W.4
Misukonis, M.A.5
Weinberg, J.B.6
-
59
-
-
0031708775
-
Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide
-
Shami PJ, Sauls DL, Weinberg JB. Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide. Leukemia 1998; 12: 1461- 6.
-
(1998)
Leukemia
, vol.12
, pp. 1461-1466
-
-
Shami, P.J.1
Sauls, D.L.2
Weinberg, J.B.3
-
60
-
-
0030786408
-
Exogenous, but not endogenous, nitric oxide increases proliferation rates in senescent human fibroblasts
-
Gansauge S, Gansauge F, Nussler AK, Rau B, Poch B, Schoenberg MH, et al. Exogenous, but not endogenous, nitric oxide increases proliferation rates in senescent human fibroblasts. FEBS Lett 1997; 410: 160-4.
-
(1997)
FEBS Lett
, vol.410
, pp. 160-164
-
-
Gansauge, S.1
Gansauge, F.2
Nussler, A.K.3
Rau, B.4
Poch, B.5
Schoenberg, M.H.6
-
61
-
-
2142649185
-
Dual actions of nitric oxide on angiogenesis: Possible roles of PKC, ERK, and AP-1
-
Jones MK, Tsugawa K, Tarnawski AS, Baatar D. Dual actions of nitric oxide on angiogenesis: possible roles of PKC, ERK, and AP-1. Biochem Biophys Res Commun 2004; 318: 520-8.
-
(2004)
Biochem Biophys Res Commun
, vol.318
, pp. 520-528
-
-
Jones, M.K.1
Tsugawa, K.2
Tarnawski, A.S.3
Baatar, D.4
-
62
-
-
60749093948
-
Growth inhibition and chemosensitization of exogenous nitric oxide released from NONOates in glioma cells in vitro
-
Weyerbrock A, Baumer B, Papazoglou A. Growth inhibition and chemosensitization of exogenous nitric oxide released from NONOates in glioma cells in vitro. J Neurosurg 2009; 110: 128-36.
-
(2009)
J Neurosurg
, vol.110
, pp. 128-136
-
-
Weyerbrock, A.1
Baumer, B.2
Papazoglou, A.3
-
63
-
-
63449100912
-
Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin
-
Fetz V, Bier C, Habtemichael N, Schuon R, Schweitzer A, Kunkel M, et al. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. Int J Cancer 2009; 124: 2033-41.
-
(2009)
Int J Cancer
, vol.124
, pp. 2033-2041
-
-
Fetz, V.1
Bier, C.2
Habtemichael, N.3
Schuon, R.4
Schweitzer, A.5
Kunkel, M.6
-
64
-
-
0035870291
-
Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: Implications for colon cancer chemoprevention
-
Williams JL, Borgo S, Hasan I, Castillo E, Traganos F, Rigas B. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention. Cancer Res 2001; 61: 3285-9.
-
(2001)
Cancer Res
, vol.61
, pp. 3285-3289
-
-
Williams, J.L.1
Borgo, S.2
Hasan, I.3
Castillo, E.4
Traganos, F.5
Rigas, B.6
-
65
-
-
28044436484
-
Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress
-
Gao J, Liu X, Rigas B. Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proc Natl Acad Sci USA 2005; 102: 17207-12.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 17207-17212
-
-
Gao, J.1
Liu, X.2
Rigas, B.3
-
66
-
-
3242778622
-
Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3
-
Royle JS, Ross JA, Ansell I, Bollina P, Tulloch DN, Habib FK. Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3. J Urol 2004; 172: 338-44.
-
(2004)
J Urol
, vol.172
, pp. 338-344
-
-
Royle, J.S.1
Ross, J.A.2
Ansell, I.3
Bollina, P.4
Tulloch, D.N.5
Habib, F.K.6
-
67
-
-
0036316922
-
Nitric oxide mediates apoptosis induction selectively in transformed fibroblasts compared to nontransformed fibroblasts
-
Heigold S, Sers C, Bechtel W, Ivanovas B, Schafer R, Bauer G. Nitric oxide mediates apoptosis induction selectively in transformed fibroblasts compared to nontransformed fibroblasts. Carcinogenesis 2002; 23: 929-41.
-
(2002)
Carcinogenesis
, vol.23
, pp. 929-941
-
-
Heigold, S.1
Sers, C.2
Bechtel, W.3
Ivanovas, B.4
Schafer, R.5
Bauer, G.6
-
68
-
-
34547138439
-
JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells
-
Kiziltepe T, Hideshima T, Ishitsuka K, Ocio EM, Raje N, Catley L, et al. JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cells. Blood 2007; 110: 709-18.
-
(2007)
Blood
, vol.110
, pp. 709-718
-
-
Kiziltepe, T.1
Hideshima, T.2
Ishitsuka, K.3
Ocio, E.M.4
Raje, N.5
Catley, L.6
-
69
-
-
0345257181
-
-
Ren Z, Kar S, Wang Z, Wang M, Saavedra JE, Carr BI. JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathways. J Cell Physiol 2003; 197: 426-34.
-
Ren Z, Kar S, Wang Z, Wang M, Saavedra JE, Carr BI. JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathways. J Cell Physiol 2003; 197: 426-34.
-
-
-
-
70
-
-
0037545338
-
JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity
-
Shami PJ, Saavedra JE, Wang LY, Bonifant CL, Diwan BA, Singh SV, et al. JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity. Mol Cancer Ther 2003; 2: 409-17.
-
(2003)
Mol Cancer Ther
, vol.2
, pp. 409-417
-
-
Shami, P.J.1
Saavedra, J.E.2
Wang, L.Y.3
Bonifant, C.L.4
Diwan, B.A.5
Singh, S.V.6
-
71
-
-
55749114587
-
TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells
-
Simeone AM, McMurtry V, Nieves-Alicea R, Saavedra JE, Keefer LK, Johnson MM, et al. TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells. Breast Cancer Res 2008; 10: R44.
-
(2008)
Breast Cancer Res
, vol.10
-
-
Simeone, A.M.1
McMurtry, V.2
Nieves-Alicea, R.3
Saavedra, J.E.4
Keefer, L.K.5
Johnson, M.M.6
-
72
-
-
0029016170
-
Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362
-
Xie K, Huang S, Dong Z, Gutman M, Fidler IJ. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res 1995; 55: 3123-31.
-
(1995)
Cancer Res
, vol.55
, pp. 3123-3131
-
-
Xie, K.1
Huang, S.2
Dong, Z.3
Gutman, M.4
Fidler, I.J.5
-
73
-
-
0032248817
-
Nitric oxide: From a mysterious labile factor to the molecule of the Nobel Prize. Recent progress in nitric oxide research
-
Xu WM, Liu LZ. Nitric oxide: from a mysterious labile factor to the molecule of the Nobel Prize. Recent progress in nitric oxide research. Cell Res 1998; 8: 251-8.
-
(1998)
Cell Res
, vol.8
, pp. 251-258
-
-
Xu, W.M.1
Liu, L.Z.2
-
74
-
-
0034280568
-
Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection
-
Soler MN, Bobe P, Benihoud K, Lemaire G, Roos BA, Lausson S. Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection. J Gene Med 2000; 2: 344-52.
-
(2000)
J Gene Med
, vol.2
, pp. 344-352
-
-
Soler, M.N.1
Bobe, P.2
Benihoud, K.3
Lemaire, G.4
Roos, B.A.5
Lausson, S.6
-
75
-
-
85047697705
-
Tumour cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: A novel suicide gene therapy
-
Worthington J, Robson T, O'Keeffe M, Hirst DG. Tumour cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy. Gene Ther 2002; 9: 263-9.
-
(2002)
Gene Ther
, vol.9
, pp. 263-269
-
-
Worthington, J.1
Robson, T.2
O'Keeffe, M.3
Hirst, D.G.4
-
76
-
-
3242798679
-
Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment
-
Worthington J, McCarthy HO, Barrett E, Adams C, Robson T, Hirst DG. Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment. J Gene Med 2004; 6: 673-80.
-
(2004)
J Gene Med
, vol.6
, pp. 673-680
-
-
Worthington, J.1
McCarthy, H.O.2
Barrett, E.3
Adams, C.4
Robson, T.5
Hirst, D.G.6
-
77
-
-
0034719333
-
Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: In vitro antileukemic activity
-
Saavedra JE, Shami PJ, Wang LY, Davies KM, Booth MN, Citro ML, et al. Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: in vitro antileukemic activity. J Med Chem 2000; 43: 261-9.
-
(2000)
J Med Chem
, vol.43
, pp. 261-269
-
-
Saavedra, J.E.1
Shami, P.J.2
Wang, L.Y.3
Davies, K.M.4
Booth, M.N.5
Citro, M.L.6
-
78
-
-
0028925540
-
Nitric oxide (NO) donor molecules: Effect of NO release rate on vascular smooth muscle cell proliferation in vitro
-
Mooradian DL, Hutsell TC, Keefer LK. Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 1995; 25: 674-8.
-
(1995)
J Cardiovasc Pharmacol
, vol.25
, pp. 674-678
-
-
Mooradian, D.L.1
Hutsell, T.C.2
Keefer, L.K.3
-
79
-
-
33745817069
-
Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl) piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivo
-
Shami PJ, Saavedra JE, Bonifant CL, Chu J, Udupi V, Malaviya S, et al. Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl) piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivo. J Med Chem 2006; 49: 4356-66.
-
(2006)
J Med Chem
, vol.49
, pp. 4356-4366
-
-
Shami, P.J.1
Saavedra, J.E.2
Bonifant, C.L.3
Chu, J.4
Udupi, V.5
Malaviya, S.6
-
80
-
-
18144365548
-
In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines
-
Tesei A, Ulivi P, Fabbri F, Rosetti M, Leonetti C, Scarsella M, et al. In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines. J Transl Med 2005; 3: 7.
-
(2005)
J Transl Med
, vol.3
, pp. 7
-
-
Tesei, A.1
Ulivi, P.2
Fabbri, F.3
Rosetti, M.4
Leonetti, C.5
Scarsella, M.6
-
81
-
-
49449090229
-
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid
-
Chen L, Zhang Y, Kong X, Lan E, Huang Z, Peng S, et al. Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid. J Med Chem 2008; 51: 4834-8.
-
(2008)
J Med Chem
, vol.51
, pp. 4834-4838
-
-
Chen, L.1
Zhang, Y.2
Kong, X.3
Lan, E.4
Huang, Z.5
Peng, S.6
-
82
-
-
49649105571
-
Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: Role of nitric oxide
-
Siemens DR, Hu N, Sheikhi AK, Chung E, Frederiksen LJ, Pross H, et al. Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: role of nitric oxide. Cancer Res 2008; 68: 4746-53.
-
(2008)
Cancer Res
, vol.68
, pp. 4746-4753
-
-
Siemens, D.R.1
Hu, N.2
Sheikhi, A.K.3
Chung, E.4
Frederiksen, L.J.5
Pross, H.6
-
83
-
-
34548052207
-
Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma
-
Perrotta C, Bizzozero L, Falcone S, Rovere-Querini P, Prinetti A, Schuchman EH, et al. Nitric oxide boosts chemoimmunotherapy via inhibition of acid sphingomyelinase in a mouse model of melanoma. Cancer Res 2007; 67: 7559-64.
-
(2007)
Cancer Res
, vol.67
, pp. 7559-7564
-
-
Perrotta, C.1
Bizzozero, L.2
Falcone, S.3
Rovere-Querini, P.4
Prinetti, A.5
Schuchman, E.H.6
-
84
-
-
47149090386
-
A phase I/II pilot trial of low-dose, sustained-release GTN for porstate cancer patients with recorrence after primary therapy
-
Seimens DR, Heaton J, Adams M, Graham C. A phase I/II pilot trial of low-dose, sustained-release GTN for porstate cancer patients with recorrence after primary therapy. Nitric Oxide 2007; 17: S15.
-
(2007)
Nitric Oxide
, vol.17
-
-
Seimens, D.R.1
Heaton, J.2
Adams, M.3
Graham, C.4
-
85
-
-
0028181674
-
Inhibition by nitric oxide of the repair protein, O6-methylguanine-DNA-methyltransferase
-
Laval F, Wink DA. Inhibition by nitric oxide of the repair protein, O6-methylguanine-DNA-methyltransferase. Carcinogenesis 1994; 15: 443-7.
-
(1994)
Carcinogenesis
, vol.15
, pp. 443-447
-
-
Laval, F.1
Wink, D.A.2
-
86
-
-
0030872132
-
Nitric oxide enhancement of melphalan-induced cytotoxicity
-
Cook JA, Krishna MC, Pacelli R, DeGraff W, Liebmann J, Mitchell JB, et al. Nitric oxide enhancement of melphalan-induced cytotoxicity. Br J Cancer 1997; 76: 325-34.
-
(1997)
Br J Cancer
, vol.76
, pp. 325-334
-
-
Cook, J.A.1
Krishna, M.C.2
Pacelli, R.3
DeGraff, W.4
Liebmann, J.5
Mitchell, J.B.6
-
87
-
-
0037331438
-
Nitric oxide donor increases the efficiency of cytostatic therapy and retards the development of drug resistance
-
Konovalova NP, Goncharova SA, Volkova LM, Rajewskaya TA, Eremenko LT, Korolev AM. Nitric oxide donor increases the efficiency of cytostatic therapy and retards the development of drug resistance. Nitric Oxide 2003; 8: 59-64.
-
(2003)
Nitric Oxide
, vol.8
, pp. 59-64
-
-
Konovalova, N.P.1
Goncharova, S.A.2
Volkova, L.M.3
Rajewskaya, T.A.4
Eremenko, L.T.5
Korolev, A.M.6
-
88
-
-
0031425653
-
Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin
-
Wink DA, Cook JA, Christodoulou D, Krishna MC, Pacelli R, Kim S, et al. Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin. Nitric Oxide 1997; 1: 88-94.
-
(1997)
Nitric Oxide
, vol.1
, pp. 88-94
-
-
Wink, D.A.1
Cook, J.A.2
Christodoulou, D.3
Krishna, M.C.4
Pacelli, R.5
Kim, S.6
-
89
-
-
0034764801
-
Nitric oxide improves cisplatin cytotoxicity in head and neck squamous cell carcinoma
-
Azizzadeh B, Yip HT, Blackwell KE, Horvath S, Calcaterra TC, Buga GM, et al. Nitric oxide improves cisplatin cytotoxicity in head and neck squamous cell carcinoma. Laryngoscope 2001; 111: 1896-900.
-
(2001)
Laryngoscope
, vol.111
, pp. 1896-1900
-
-
Azizzadeh, B.1
Yip, H.T.2
Blackwell, K.E.3
Horvath, S.4
Calcaterra, T.C.5
Buga, G.M.6
-
90
-
-
41049090416
-
NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols
-
Bratasz A, Selvendiran K, Wasowicz T, Bobko A, Khramtsov VV, Ignarro LJ, et al. NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols. J Transl Med 2008 26; 6: 9.
-
(2008)
J Transl Med
, vol.26
, Issue.6
, pp. 9
-
-
Bratasz, A.1
Selvendiran, K.2
Wasowicz, T.3
Bobko, A.4
Khramtsov, V.V.5
Ignarro, L.J.6
-
91
-
-
33646575901
-
Efficacy of a nitric oxide-releasing nonsteroidal antiinflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts
-
Leonetti C, Scarsella M, Zupi G, Zoli W, Amadori D, Medri L, et al. Efficacy of a nitric oxide-releasing nonsteroidal antiinflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts. Mol Cancer Ther 2006; 5: 919-26.
-
(2006)
Mol Cancer Ther
, vol.5
, pp. 919-926
-
-
Leonetti, C.1
Scarsella, M.2
Zupi, G.3
Zoli, W.4
Amadori, D.5
Medri, L.6
-
92
-
-
33644857843
-
Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin
-
Bratasz A, Weir NM, Parinandi NL, Zweier JL, Sridhar R, Ignarro LJ, et al. Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin. Proc Natl Acad Sci USA 2006; 103: 3914-9.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 3914-3919
-
-
Bratasz, A.1
Weir, N.M.2
Parinandi, N.L.3
Zweier, J.L.4
Sridhar, R.5
Ignarro, L.J.6
-
93
-
-
62249103012
-
Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells
-
Adams C, McCarthy HO, Coulter JA, Worthington J, Murphy C, Robson T, et al. Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells. J Gene Med 2009; 11: 160-8.
-
(2009)
J Gene Med
, vol.11
, pp. 160-168
-
-
Adams, C.1
McCarthy, H.O.2
Coulter, J.A.3
Worthington, J.4
Murphy, C.5
Robson, T.6
-
94
-
-
0035199021
-
Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes
-
Adams DJ, Levesque MC, Weinberg JB, Smith KL, Flowers JL, Moore J, et al. Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes. Leukemia 2001; 15: 1852-9.
-
(2001)
Leukemia
, vol.15
, pp. 1852-1859
-
-
Adams, D.J.1
Levesque, M.C.2
Weinberg, J.B.3
Smith, K.L.4
Flowers, J.L.5
Moore, J.6
-
95
-
-
0035915458
-
Nitric oxide-mediated regulation of chemosensitivity in cancer cells
-
Matthews NE, Adams MA, Maxwell LR, Gofton TE, Graham CH. Nitric oxide-mediated regulation of chemosensitivity in cancer cells. J Natl Cancer Inst 2001; 93: 1879-85.
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 1879-1885
-
-
Matthews, N.E.1
Adams, M.A.2
Maxwell, L.R.3
Gofton, T.E.4
Graham, C.H.5
-
96
-
-
0043239001
-
Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate
-
Frederiksen LJ, Siemens DR, Heaton JP, Maxwell LR, Adams MA, Graham CH. Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate. J Urol 2003; 170: 1003-7.
-
(2003)
J Urol
, vol.170
, pp. 1003-1007
-
-
Frederiksen, L.J.1
Siemens, D.R.2
Heaton, J.P.3
Maxwell, L.R.4
Adams, M.A.5
Graham, C.H.6
-
97
-
-
33645235263
-
Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells
-
Muir CP, Adams MA, Graham CH. Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells. Breast Cancer Res Treat 2006; 96: 69-76.
-
(2006)
Breast Cancer Res Treat
, vol.96
, pp. 69-76
-
-
Muir, C.P.1
Adams, M.A.2
Graham, C.H.3
-
98
-
-
34247511420
-
Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling
-
Frederiksen LJ, Sullivan R, Maxwell LR, Macdonald-Goodfellow SK, Adams MA, Bennett BM, et al. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling. Clin Cancer Res 2007; 13: 2199-206.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 2199-2206
-
-
Frederiksen, L.J.1
Sullivan, R.2
Maxwell, L.R.3
Macdonald-Goodfellow, S.K.4
Adams, M.A.5
Bennett, B.M.6
-
99
-
-
33845303951
-
Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma
-
Yasuda H, Nakayama K, Watanabe M, Suzuki S, Fuji H, Okinaga S, et al. Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma. Clin Cancer Res 2006; 12: 6748-57.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 6748-6757
-
-
Yasuda, H.1
Nakayama, K.2
Watanabe, M.3
Suzuki, S.4
Fuji, H.5
Okinaga, S.6
-
100
-
-
47149085610
-
Solid tumor physiology and hypoxia-induced chemo/radio- resistance: Novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer
-
Yasuda H. Solid tumor physiology and hypoxia-induced chemo/radio- resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer. Nitric Oxide 2008; 19: 205-16.
-
(2008)
Nitric Oxide
, vol.19
, pp. 205-216
-
-
Yasuda, H.1
-
101
-
-
33646248643
-
Nitric oxide modulates proapoptotic and antiapoptotic properties of chemotherapy agents: The case of NO-pegylated epirubicin
-
Santucci L, Mencarelli A, Renga B, Pasut G, Veronese F, Zacheo A, et al. Nitric oxide modulates proapoptotic and antiapoptotic properties of chemotherapy agents: the case of NO-pegylated epirubicin. FASEB J 2006; 20: 765-7.
-
(2006)
FASEB J
, vol.20
, pp. 765-767
-
-
Santucci, L.1
Mencarelli, A.2
Renga, B.3
Pasut, G.4
Veronese, F.5
Zacheo, A.6
-
102
-
-
2442702027
-
Endogenous production and exogenous exposure to nitric oxide augment doxorubicin cytotoxicity for breast cancer cells but not cardiac myoblasts
-
Evig CB, Kelley EE, Weydert CJ, Chu Y, Buettner GR, Burns CP. Endogenous production and exogenous exposure to nitric oxide augment doxorubicin cytotoxicity for breast cancer cells but not cardiac myoblasts. Nitric Oxide 2004; 10: 119-29.
-
(2004)
Nitric Oxide
, vol.10
, pp. 119-129
-
-
Evig, C.B.1
Kelley, E.E.2
Weydert, C.J.3
Chu, Y.4
Buettner, G.R.5
Burns, C.P.6
-
103
-
-
0043239001
-
Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate
-
Frederiksen LJ, Siemens DR, Heaton JP, Maxwell LR, Adams MA, Graham CH. Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate. J Urol 2003; 170: 1003-7.
-
(2003)
J Urol
, vol.170
, pp. 1003-1007
-
-
Frederiksen, L.J.1
Siemens, D.R.2
Heaton, J.P.3
Maxwell, L.R.4
Adams, M.A.5
Graham, C.H.6
-
104
-
-
33846863589
-
Nitric oxide and peroxynitrite in health and disease
-
Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315-424.
-
(2007)
Physiol Rev
, vol.87
, pp. 315-424
-
-
Pacher, P.1
Beckman, J.S.2
Liaudet, L.3
-
105
-
-
33644838950
-
Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer
-
Yasuda H, Yamaya M, Nakayama K, Sasaki T, Ebihara S, Kanda A, et al. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer. J Clin Oncol 2006; 24: 688-94.
-
(2006)
J Clin Oncol
, vol.24
, pp. 688-694
-
-
Yasuda, H.1
Yamaya, M.2
Nakayama, K.3
Sasaki, T.4
Ebihara, S.5
Kanda, A.6
-
106
-
-
61449213235
-
The mineralocorticoid receptor in endothelial physiology and disease: Novel concepts in the understanding of erectile dysfunction
-
Caprio M, Mammi C, Jaffe IZ, Zennaro MC, Aversa A, Mendelsohn ME, Fabbri A, Rosano G M. The mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of erectile dysfunction. Curr Pharm Des 2008; 14(35): 3749-57.
-
(2008)
Curr Pharm Des
, vol.14
, Issue.35
, pp. 3749-3757
-
-
Caprio, M.1
Mammi, C.2
Jaffe, I.Z.3
Zennaro, M.C.4
Aversa, A.5
Mendelsohn, M.E.6
Fabbri, A.7
Rosano, G.M.8
-
107
-
-
52949124436
-
The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignancies
-
Secchiero P, di Iasio MG, Gonelli A, Zauli G. The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignancies. Curr Pharm Des 2008; 14(21): 2100-10.
-
(2008)
Curr Pharm Des
, vol.14
, Issue.21
, pp. 2100-2110
-
-
Secchiero, P.1
di Iasio, M.G.2
Gonelli, A.3
Zauli, G.4
-
108
-
-
61449091715
-
The brain, the penis and steroid hormones: Clinical correlates with endothelial dysfunction
-
Traish AM, Abu-Zahra H, Guay AT. The brain, the penis and steroid hormones: clinical correlates with endothelial dysfunction. Curr Pharm Des 2008; 14(35): 3723-36.
-
(2008)
Curr Pharm Des
, vol.14
, Issue.35
, pp. 3723-3736
-
-
Traish, A.M.1
Abu-Zahra, H.2
Guay, A.T.3
|